Latest News about REGN
Recent news which mentions REGN
Aclaris Therapeutics' ATI-1777 Faces Uphill Battle In Atopic Dermatitis Treatment Landscape, Analyst Downgrades
January 22, 2024
From Benzinga
2 Smart Growth Stocks to Buy Hand Over Fist in 2024
January 21, 2024
From Motley Fool
EXCLUSIVE: The 'Buy Everything' Market Is Over: Synopsys-Ansys Merger Provides Fertile Ground For This Stock Picker
January 18, 2024
From Benzinga
From InvestorPlace
Regeneron Pharma's Pipeline Makes This Analyst Turn Bullish
January 12, 2024
From Benzinga
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
January 04, 2024
From Benzinga
2 Healthcare Stocks That Turned $1,000 Into $2,400 (or More)
January 04, 2024
From Motley Fool
Regeneron Celebrates Legal Win: Court Upholds Eylea Medication Patent
December 28, 2023
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
December 27, 2023
From Benzinga
How Is The Market Feeling About Regeneron Pharmaceuticals?
December 27, 2023
Tickers
REGN
From Benzinga
Unpacking the Latest Options Trading Trends in Regeneron Pharmaceuticals
December 22, 2023
Tickers
REGN
From Benzinga
7 Undervalued Nasdaq-100 Stocks for Bargain Hunters
December 21, 2023
Tags
NASDAQ:QCOM,NASDAQ:KLAC,NASDAQ:AMAT,NASDAQ:CEG,NASDAQ:REGN,NASDAQ:CMCSA,NASDAQ:CHTR
Market News
CEG
From InvestorPlace
$1000 Invested In Regeneron Pharmaceuticals 10 Years Ago Would Be Worth This Much Today
December 21, 2023
Tickers
REGN
From Benzinga
14 Analysts Assess Regeneron Pharmaceuticals: What You Need To Know
December 18, 2023
Tickers
REGN
From Benzinga
Price Over Earnings Overview: Regeneron Pharmaceuticals
December 18, 2023
Tickers
REGN
From Benzinga
It's Almost 2024: 3 Top Stocks to Buy Before the New Year
December 17, 2023
From Motley Fool
AI Meets Biotech: 3 Top Stocks Transforming Medical Science
December 16, 2023
From InvestorPlace
3 Stocks to Buy Before 2024 That Can Set You Up For Life
December 14, 2023
From Motley Fool
3 Gene-Editing Stocks With the Potential to Mint Millionaires
December 13, 2023
From InvestorPlace
(REGN) - Analyzing Regeneron Pharmaceuticals's Short Interest
December 11, 2023
Tickers
REGN
From Benzinga
Could Regeneron Pharmaceuticals Stock Help You Become a Millionaire?
December 08, 2023
Tickers
REGN
From Motley Fool
You Don't Have to Pick a Winner in Gene-Editing. Do This Instead.
December 04, 2023
From Motley Fool
GOOG Stock Alert: Alphabet Is Spending Money in All the Wrong Places
December 02, 2023
From InvestorPlace
$1000 Invested In Regeneron Pharmaceuticals 15 Years Ago Would Be Worth This Much Today
December 01, 2023
Tickers
REGN
From Benzinga
11 Analysts Have This to Say About Regeneron Pharmaceuticals
November 28, 2023
Tickers
REGN
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
